Pages
- Event Confirmation
- Site Map
- About
- Contact Us Confirmation
- Contact Us
- Current Openings
- News & Events
- Resources
- Services
- Blog
- Home
- Privacy Policy
News
- Matica Biotechnology Appoints Life Sciences Leader Min Park, MBA to Chief Commercial Officer
- Transforming Viral Vector Analytics: Matica Bio’s Innovative Approach to Capsid Analysis
- Matica Biotechnology Establishes CDMO Partnership with KaliVir Immunotherapeutics
- Strategic Partnership Between Matica Bio and Mongoose Bio to Accelerate TCR-T Cell Therapy Development
- Matica Bio and CytoImmune Establish a Strategic Partnership for Cell Therapy Development and Manufacturing
- Matica Bio at BIO International 2024: Leading the Way in CGT Innovation and U.S. Manufacturing Strategy
- Matica Biotechnology: Filling the void
- Matica Bio Appoints Life Sciences Veteran Paul Kim as Chief Executive Officer
- Advanced Therapy Grapples with Standardized Techniques
- Matica Bio Welcomes Four Life Sciences Visionaries as Members of Advisory Board
- Innovations and Trends in Aseptic Manufacturing Processes
- Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions
- The Role Manufacturing Will Play in Advancing CGTs
- Matica Bio Launches MatiMax™ Cell Lines at BIO International Convention
- Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event
- Matica Bio Opens New Cell & Gene Therapy GMP Facility in Texas
- CHA Medical & Bio Group Announces Groundbreaking for Its New Cell Gene Biobank Facility
- Matica Bio Announces Joint Research Agreement with Sartorius for the Development of Advanced Viral Vector Manufacturing Technology
- Matica Biotechnology, Inc. Appoints Yun Jeong Song as new CEO
- As viral vector demand surges, CDMO Matica establishes a beachhead in Texas
- Matica Biotechnology, Inc. Announces Master Research Agreement with Texas A&M
- Matica Biotechnology, Inc. Announces Groundbreaking for New GMP Facility
- Matica Biotechnology, Inc. Announces Plans to Construct GMP Facility for Viral Vector Production
- CHA Biotech to Raise $62 mn to Bolster CDMO Business
Events
- 2nd Cell and Gene Tech Investment (CGTI) Forum
- 2024 iC3 Summit
- [Matica Event] Lunch and Learn in Phily
- Gene Therapy for Rare Disorders
- Cell and Gene Meeting on the MESA
- ASGCT 2024
- BIO International 2024
- Cell and Gene Tech Investment Forum
- BPI West 2024
- Advanced Therapies Week 2024
- J.P. Morgan Healthcare Conference
- Biotech Showcase 2024
- KoNECT-MOHW-MFDS International Conference
- Biomanufacturing World Summit 2023
- KASBP 2023 Fall Symposium
- Global Forum on Future Medicine
- iC³ Life Science Summit
- 2023 ASCO Annual Meeting
- Cell and Gene Meeting on the Mesa
- BioProcess International
- BIO International
- ASGCT 2023
- World Vaccine Congress Washington
- Advanced Therapies Week - Phacilitate
- Biotech Showcase 2023
- JP Morgan Healthcare Conference
- 7th Oncolytic Virotherapy Summit
- Cell & Gene Meeting on the Mesa 2022
- BioProcess International 2022
- Meet us at Biotech Showcase 2021 Digital!
- Matica Bio is attending 4th Annual Gene Therapy for Rare Disorders
- Matica Biotechnology participates in Cell and Gene Meeting on the Med Conference!
- Matica Biotechnology is attending Wet AMD & DME Drug Development Summit
- Meet us at World Vaccine Congress Washington!
- Matica Bio is participating in ASGCT 24th Annual Meeting
- Matica Bio is attending Advanced Therapies 2021
- Join us at BIO Digital 2021
- Join us at BPI 2021
- Join us at Cell & Gene Meeting on the MESA
- Meet us at Biotech Showcase 2022
- Meet us at Advanced Therapies Week
- World Vaccine Congress Washington
- ASGCT 2022
- BIO International Convention 2022